Streetbeat News

Stock Prices

EOG

EOG Resources (NYSE:EOG) has outperformed the market over the past 20 years with an average annual return of 10.43%. A $1000 investment in EOG 20 years ago would be worth $7,282.96 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 7:01 pm

OMC

Analysts have mixed ratings for Omnicom Group (NYSE:OMC), with recent price targets averaging $109.25, up from $105.00. Analysts from JP Morgan, B of A Securities, UBS, and Macquarie have adjusted their ratings and price targets, reflecting varied market perceptions. Omnicom shows strong financial health with a high net margin and ROE, but its debt-to-equity ratio is higher than industry averages.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 7:01 pm

DLR

Analysts have provided mixed ratings for Digital Realty Trust (NYSE:DLR) over the past three months, with a recent positive shift in average price targets. The company's financial metrics, such as revenue growth, net margin, ROE, and ROA, are below industry averages, indicating potential challenges. However, its debt management is healthier compared to peers.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 7:00 pm

ETHUSD

Ethereum's price has decreased by 3.42% in the last 24 hours, continuing a week-long decline of 5%. Despite the price drop, trading volume has increased by 33% over the past week, while the circulating supply slightly decreased. Ethereum's market cap is ranked #2 at $300.77 billion.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 7:00 pm

NFE

New Fortress Energy (NFE) shares are rising after announcing a $400 million stock offering, with CEO Wesley Edens purchasing a significant portion. The offering is expected to close on Oct. 2, with proceeds for general corporate purposes. The stock also benefits from energy sector gains amid Middle East tensions.

Portfolio Pulse from Adam Eckert

October 01, 2024 | 6:57 pm

NVO

NVS

The US Department of Health and Human Services announced cost savings for 54 prescription drugs under Medicare Part B, effective from October 2024. This initiative aims to counter drug price hikes exceeding inflation, benefiting over 822,000 Medicare beneficiaries. Notably, Novartis' cancer drug Kymriah could save patients up to $3,000. The Inflation Reduction Act's initiatives will continue to reduce drug prices, with potential inclusion of Novo Nordisk's Ozempic in future negotiations.

Portfolio Pulse from Vandana Singh

October 01, 2024 | 6:51 pm

AAVE

BTC

PENDLE

SOL

A Binance trader predicts a bullish Q4 for Bitcoin, expecting a short-term pullback before a rise. The trader's crypto shopping list includes Solana, Dogwifhat, Pepe, Popcat, Aave, and Pendle. Despite declining active addresses, a shift to quantitative easing could boost the market.

Portfolio Pulse from Khyathi Dalal

October 01, 2024 | 6:48 pm

CVX

HES

XOM

Hess Corporation and Chevron Corporation shares are trading higher following the FTC's completion of an antitrust review for their merger. Analysts have raised Hess' valuation due to increased resources in Guyana, and Hess is seen as a compelling value opportunity. Wolfe Research upgraded Hess, citing attractive risk/reward profiles in various scenarios, including a potential merger with Chevron.

Portfolio Pulse from Lekha Gupta

October 01, 2024 | 6:45 pm

EIS

ISRA

Israeli media reports that Israel's military plans to continue conducting powerful airstrikes throughout the Middle East tonight.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 6:45 pm

MDLZ

Mondelez International (NYSE:MDLZ) has seen a 5.71% increase in its short percent of float, now at 1.11% of available shares. This indicates a rise in bearish sentiment, although it remains below the peer group average of 4.61%.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 6:45 pm